Sekretessinställningar
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Aktiemarknader
    • BörsRealtidskurser, index och marknadsutveckling
    • MorgonrapportDaglig marknadssammanfattning och nattens viktigaste händelser
    • BörskalenderKommande resultat, noteringar och företagshändelser
    • UtdelningskalenderKommande och tidigare utdelningar
  • Bolag
    • BolagBläddra och filtrera hela listan över noterade bolag
    • UpptäckInspiration till din nästa investering
    • BörsnoteringarNya noteringar och kommande börsintroduktioner
    • ÅrsstämmorDatum för årsstämmor och aktieägarinformation
  • Aktieforskning
    • AktieanalysExpertaktieanalys och rekommendationer
    • ArtiklarNyheter, insikter och marknadskommentarer
    • PortföljInderes modellportfölj
    • inderesTVVideohub för aktieanalys, forskning och expertkommentarer
    • TranskriptionerFullständiga utskrifter av resultatsamtal och investerarmöten
    • AktiejämförelseJämför nyckeltal och utveckling för flera aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Q&A
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer

Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.

Inside Information: Modulight has received a $1.5 million pilot production order from a U.S. neuroscience customer

MODURegulatoriskt pressmeddelande2026-09-15 12:25
Discuss

Modulight Corporation | Inside Information | September 15, 2026 at 13:25:00 EEST

Modulight Corporation has received a $1.5 million pilot production purchase order from an existing U.S. venture customer for semiconductor laser products used in a neuroscience application. Modulight has collaborated with the customer for several years to develop laser technology for the application.

Deliveries under the new order will start immediately and are scheduled to continue monthly over the next 12 months. The order represents a transition to pilot production and a significant increase in volumes compared with previous deliveries. The customer has agreed to make prepayments covering all materials required for the ordered products.

The customer develops advanced technology for measuring brain activity and is seeing increasing demand driven by advances in neuroscience and artificial intelligence, as well as their convergence.

“We are very pleased to see our long-term collaboration with this customer progressing to pilot production. Advances in artificial intelligence are creating new possibilities for understanding brain activity, while neuroscience is providing increasingly sophisticated data for AI-based models. This is a field where our specialized laser technology can play an important enabling role,” says Seppo Orsila, CEO of Modulight.

For further information, please contact:


CEO Seppo Orsila, m. +358 40 830 4671

IR Ulla Haapanen, m. +358 40 830 4676
Email: ir@modulight.com

Certified adviser: Sisu Partners Oy, m. +358 40 555 4727
 
modulight.com
@modulight

Modulight in brief


Modulight Corporation is a life science company that designs and manufactures laser devices for the treatment of cancer and eye diseases. The company also manufactures products for other high value-add applications including flow cytometry, microscopy, semiconductor, quantum, and defense. The company’s products include medical devices, subsystems, software, cloud services, and specialized semiconductors. Modulight’s products are used worldwide by many Fortune 500 companies, pharmaceutical companies, and well-known cancer centers and universities. Modulight was founded in 2000 and is headquartered in Tampere, Finland.

Follow Modulight: modulight.com | X | LinkedIn | Facebook | YouTube | Instagram | #KillCancer